Temporal Bone Osteoradionecrosis: An 18‐year, Single‐Institution Experience
Objectives/Hypothesis To report the largest single‐institution review of temporal bone osteoradionecrosis (TBORN), and characterize the disease's natural history, prognostic factors, management, and outcomes. Study Design Retrospective chart review. Methods Retrospective review was conducted to...
Gespeichert in:
Veröffentlicht in: | The Laryngoscope 2021-11, Vol.131 (11), p.2578-2585 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2585 |
---|---|
container_issue | 11 |
container_start_page | 2578 |
container_title | The Laryngoscope |
container_volume | 131 |
creator | Lovin, Benjamin D. Hernandez, Mike Elms, Hunter Choi, Jonathan S. Lindquist, Nathan R. Moreno, Amy C. Nader, Marc‐Elie Gidley, Paul W. |
description | Objectives/Hypothesis
To report the largest single‐institution review of temporal bone osteoradionecrosis (TBORN), and characterize the disease's natural history, prognostic factors, management, and outcomes.
Study Design
Retrospective chart review.
Methods
Retrospective review was conducted to identify patients with TBORN. Pertinent data were extracted. Descriptive statistics were used to summarize patient, tumor, and treatment characteristics. Multivariable analyses were conducted to explore associations between these characteristics and time to TBORN diagnosis and risk of developing diffuse disease.
Results
TBORN was identified in 145 temporal bones from 128 patients. Mean age at diagnosis was 62 years, and mean time to diagnosis after radiotherapy was 10 years. Age greater than 50 years was associated with earlier diagnosis. According to the Ramsden criteria, 76% of TBs had localized and 24% had diffuse disease at initial diagnosis; 37% had diffuse disease at last follow‐up. On multivariable analysis, diabetes, three‐dimensional conformal radiotherapy (3D‐CRT), and periauricular skin malignancy were significant risk factors for developing diffuse disease. Localized disease was successfully managed with conservative measures, whereas surgery was often necessary for diffuse disease. When TBORN spread outside the mastoid or infratemporal fossa, conservative measures were always unsuccessful.
Conclusions
TBORN occurs earlier in older patients. While diffuse disease is less common than localized disease, it occurs more frequently in patients with diabetes, history of 3D‐CRT, and periauricular skin malignancies. Conservative management is appropriate for localized disease, while surgery is often necessary for diffuse disease. The prognostic factors identified helped propose a TBORN staging system and treatment guidelines which may improve patient risk stratification and disease management.
Level of Evidence
4 Laryngoscope, 131:2578–2585, 2021 |
doi_str_mv | 10.1002/lary.29758 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9214913</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2553818414</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4258-d57599d12f7db4392f553059be3cf8669973e3ec2f7990a42d804ac6ff2be4ab3</originalsourceid><addsrcrecordid>eNp9kctKxDAUhoMoOl42PkHBjYjVXKeJC2EUbzAw4AV0FdL2VCOddExadXY-gs_ok5hxRNCFi3D4-b_8nAtCmwTvEYzpfm38dI-qTMgF1COCkZQrJRZRL5oslYLerqDVEB4xJhkTeBmtME5lJpXsodE1jCeNN3Vy1DhIRqGFqEobReGbYMNBMnAJkR9v71Mwfje5su6-higvXGht27URTU5eJ-AtuALW0VJl6gAb33UN3ZyeXB-fp8PR2cXxYJgWnAqZliITSpWEVlmZc6ZoJQTDQuXAikr2-0plDBgU0VcKG05Libkp-lVFc-AmZ2vocJ476fIxlAW4Ng6hJ96O4zZ0Y6z-7Tj7oO-bZ60o4YqwGLD9HeCbpw5Cq8c2FFDXxkHTBU1jQ5JITnhEt_6gj03nXRwvUhLHlxESqZ05Ndtb8FD9NEOwnt1Jz-6kv-4UYTKHX2wN039IPRxc3s3_fAJX95Z-</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2580258711</pqid></control><display><type>article</type><title>Temporal Bone Osteoradionecrosis: An 18‐year, Single‐Institution Experience</title><source>Wiley Online Library Journals Frontfile Complete</source><creator>Lovin, Benjamin D. ; Hernandez, Mike ; Elms, Hunter ; Choi, Jonathan S. ; Lindquist, Nathan R. ; Moreno, Amy C. ; Nader, Marc‐Elie ; Gidley, Paul W.</creator><creatorcontrib>Lovin, Benjamin D. ; Hernandez, Mike ; Elms, Hunter ; Choi, Jonathan S. ; Lindquist, Nathan R. ; Moreno, Amy C. ; Nader, Marc‐Elie ; Gidley, Paul W.</creatorcontrib><description>Objectives/Hypothesis
To report the largest single‐institution review of temporal bone osteoradionecrosis (TBORN), and characterize the disease's natural history, prognostic factors, management, and outcomes.
Study Design
Retrospective chart review.
Methods
Retrospective review was conducted to identify patients with TBORN. Pertinent data were extracted. Descriptive statistics were used to summarize patient, tumor, and treatment characteristics. Multivariable analyses were conducted to explore associations between these characteristics and time to TBORN diagnosis and risk of developing diffuse disease.
Results
TBORN was identified in 145 temporal bones from 128 patients. Mean age at diagnosis was 62 years, and mean time to diagnosis after radiotherapy was 10 years. Age greater than 50 years was associated with earlier diagnosis. According to the Ramsden criteria, 76% of TBs had localized and 24% had diffuse disease at initial diagnosis; 37% had diffuse disease at last follow‐up. On multivariable analysis, diabetes, three‐dimensional conformal radiotherapy (3D‐CRT), and periauricular skin malignancy were significant risk factors for developing diffuse disease. Localized disease was successfully managed with conservative measures, whereas surgery was often necessary for diffuse disease. When TBORN spread outside the mastoid or infratemporal fossa, conservative measures were always unsuccessful.
Conclusions
TBORN occurs earlier in older patients. While diffuse disease is less common than localized disease, it occurs more frequently in patients with diabetes, history of 3D‐CRT, and periauricular skin malignancies. Conservative management is appropriate for localized disease, while surgery is often necessary for diffuse disease. The prognostic factors identified helped propose a TBORN staging system and treatment guidelines which may improve patient risk stratification and disease management.
Level of Evidence
4 Laryngoscope, 131:2578–2585, 2021</description><identifier>ISSN: 0023-852X</identifier><identifier>EISSN: 1531-4995</identifier><identifier>DOI: 10.1002/lary.29758</identifier><identifier>PMID: 34287898</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley & Sons, Inc</publisher><subject>Diabetes ; Laryngoscopy ; osteoradionecrosis ; Patients ; radiation ; Radiation therapy ; Skin cancer ; Temporal bone</subject><ispartof>The Laryngoscope, 2021-11, Vol.131 (11), p.2578-2585</ispartof><rights>2021 The American Laryngological, Rhinological and Otological Society, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4258-d57599d12f7db4392f553059be3cf8669973e3ec2f7990a42d804ac6ff2be4ab3</citedby><cites>FETCH-LOGICAL-c4258-d57599d12f7db4392f553059be3cf8669973e3ec2f7990a42d804ac6ff2be4ab3</cites><orcidid>0000-0002-5074-5460 ; 0000-0001-9015-4895 ; 0000-0003-3706-8781 ; 0000-0001-6762-6807 ; 0000-0001-8923-6527 ; 0000-0003-1509-8971 ; 0000-0003-2008-518X ; 0000-0001-9295-0174</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Flary.29758$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Flary.29758$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,776,780,881,1411,27901,27902,45550,45551</link.rule.ids></links><search><creatorcontrib>Lovin, Benjamin D.</creatorcontrib><creatorcontrib>Hernandez, Mike</creatorcontrib><creatorcontrib>Elms, Hunter</creatorcontrib><creatorcontrib>Choi, Jonathan S.</creatorcontrib><creatorcontrib>Lindquist, Nathan R.</creatorcontrib><creatorcontrib>Moreno, Amy C.</creatorcontrib><creatorcontrib>Nader, Marc‐Elie</creatorcontrib><creatorcontrib>Gidley, Paul W.</creatorcontrib><title>Temporal Bone Osteoradionecrosis: An 18‐year, Single‐Institution Experience</title><title>The Laryngoscope</title><description>Objectives/Hypothesis
To report the largest single‐institution review of temporal bone osteoradionecrosis (TBORN), and characterize the disease's natural history, prognostic factors, management, and outcomes.
Study Design
Retrospective chart review.
Methods
Retrospective review was conducted to identify patients with TBORN. Pertinent data were extracted. Descriptive statistics were used to summarize patient, tumor, and treatment characteristics. Multivariable analyses were conducted to explore associations between these characteristics and time to TBORN diagnosis and risk of developing diffuse disease.
Results
TBORN was identified in 145 temporal bones from 128 patients. Mean age at diagnosis was 62 years, and mean time to diagnosis after radiotherapy was 10 years. Age greater than 50 years was associated with earlier diagnosis. According to the Ramsden criteria, 76% of TBs had localized and 24% had diffuse disease at initial diagnosis; 37% had diffuse disease at last follow‐up. On multivariable analysis, diabetes, three‐dimensional conformal radiotherapy (3D‐CRT), and periauricular skin malignancy were significant risk factors for developing diffuse disease. Localized disease was successfully managed with conservative measures, whereas surgery was often necessary for diffuse disease. When TBORN spread outside the mastoid or infratemporal fossa, conservative measures were always unsuccessful.
Conclusions
TBORN occurs earlier in older patients. While diffuse disease is less common than localized disease, it occurs more frequently in patients with diabetes, history of 3D‐CRT, and periauricular skin malignancies. Conservative management is appropriate for localized disease, while surgery is often necessary for diffuse disease. The prognostic factors identified helped propose a TBORN staging system and treatment guidelines which may improve patient risk stratification and disease management.
Level of Evidence
4 Laryngoscope, 131:2578–2585, 2021</description><subject>Diabetes</subject><subject>Laryngoscopy</subject><subject>osteoradionecrosis</subject><subject>Patients</subject><subject>radiation</subject><subject>Radiation therapy</subject><subject>Skin cancer</subject><subject>Temporal bone</subject><issn>0023-852X</issn><issn>1531-4995</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kctKxDAUhoMoOl42PkHBjYjVXKeJC2EUbzAw4AV0FdL2VCOddExadXY-gs_ok5hxRNCFi3D4-b_8nAtCmwTvEYzpfm38dI-qTMgF1COCkZQrJRZRL5oslYLerqDVEB4xJhkTeBmtME5lJpXsodE1jCeNN3Vy1DhIRqGFqEobReGbYMNBMnAJkR9v71Mwfje5su6-higvXGht27URTU5eJ-AtuALW0VJl6gAb33UN3ZyeXB-fp8PR2cXxYJgWnAqZliITSpWEVlmZc6ZoJQTDQuXAikr2-0plDBgU0VcKG05Libkp-lVFc-AmZ2vocJ476fIxlAW4Ng6hJ96O4zZ0Y6z-7Tj7oO-bZ60o4YqwGLD9HeCbpw5Cq8c2FFDXxkHTBU1jQ5JITnhEt_6gj03nXRwvUhLHlxESqZ05Ndtb8FD9NEOwnt1Jz-6kv-4UYTKHX2wN039IPRxc3s3_fAJX95Z-</recordid><startdate>202111</startdate><enddate>202111</enddate><creator>Lovin, Benjamin D.</creator><creator>Hernandez, Mike</creator><creator>Elms, Hunter</creator><creator>Choi, Jonathan S.</creator><creator>Lindquist, Nathan R.</creator><creator>Moreno, Amy C.</creator><creator>Nader, Marc‐Elie</creator><creator>Gidley, Paul W.</creator><general>John Wiley & Sons, Inc</general><general>Wiley Subscription Services, Inc</general><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-5074-5460</orcidid><orcidid>https://orcid.org/0000-0001-9015-4895</orcidid><orcidid>https://orcid.org/0000-0003-3706-8781</orcidid><orcidid>https://orcid.org/0000-0001-6762-6807</orcidid><orcidid>https://orcid.org/0000-0001-8923-6527</orcidid><orcidid>https://orcid.org/0000-0003-1509-8971</orcidid><orcidid>https://orcid.org/0000-0003-2008-518X</orcidid><orcidid>https://orcid.org/0000-0001-9295-0174</orcidid></search><sort><creationdate>202111</creationdate><title>Temporal Bone Osteoradionecrosis: An 18‐year, Single‐Institution Experience</title><author>Lovin, Benjamin D. ; Hernandez, Mike ; Elms, Hunter ; Choi, Jonathan S. ; Lindquist, Nathan R. ; Moreno, Amy C. ; Nader, Marc‐Elie ; Gidley, Paul W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4258-d57599d12f7db4392f553059be3cf8669973e3ec2f7990a42d804ac6ff2be4ab3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Diabetes</topic><topic>Laryngoscopy</topic><topic>osteoradionecrosis</topic><topic>Patients</topic><topic>radiation</topic><topic>Radiation therapy</topic><topic>Skin cancer</topic><topic>Temporal bone</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lovin, Benjamin D.</creatorcontrib><creatorcontrib>Hernandez, Mike</creatorcontrib><creatorcontrib>Elms, Hunter</creatorcontrib><creatorcontrib>Choi, Jonathan S.</creatorcontrib><creatorcontrib>Lindquist, Nathan R.</creatorcontrib><creatorcontrib>Moreno, Amy C.</creatorcontrib><creatorcontrib>Nader, Marc‐Elie</creatorcontrib><creatorcontrib>Gidley, Paul W.</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Laryngoscope</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lovin, Benjamin D.</au><au>Hernandez, Mike</au><au>Elms, Hunter</au><au>Choi, Jonathan S.</au><au>Lindquist, Nathan R.</au><au>Moreno, Amy C.</au><au>Nader, Marc‐Elie</au><au>Gidley, Paul W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Temporal Bone Osteoradionecrosis: An 18‐year, Single‐Institution Experience</atitle><jtitle>The Laryngoscope</jtitle><date>2021-11</date><risdate>2021</risdate><volume>131</volume><issue>11</issue><spage>2578</spage><epage>2585</epage><pages>2578-2585</pages><issn>0023-852X</issn><eissn>1531-4995</eissn><abstract>Objectives/Hypothesis
To report the largest single‐institution review of temporal bone osteoradionecrosis (TBORN), and characterize the disease's natural history, prognostic factors, management, and outcomes.
Study Design
Retrospective chart review.
Methods
Retrospective review was conducted to identify patients with TBORN. Pertinent data were extracted. Descriptive statistics were used to summarize patient, tumor, and treatment characteristics. Multivariable analyses were conducted to explore associations between these characteristics and time to TBORN diagnosis and risk of developing diffuse disease.
Results
TBORN was identified in 145 temporal bones from 128 patients. Mean age at diagnosis was 62 years, and mean time to diagnosis after radiotherapy was 10 years. Age greater than 50 years was associated with earlier diagnosis. According to the Ramsden criteria, 76% of TBs had localized and 24% had diffuse disease at initial diagnosis; 37% had diffuse disease at last follow‐up. On multivariable analysis, diabetes, three‐dimensional conformal radiotherapy (3D‐CRT), and periauricular skin malignancy were significant risk factors for developing diffuse disease. Localized disease was successfully managed with conservative measures, whereas surgery was often necessary for diffuse disease. When TBORN spread outside the mastoid or infratemporal fossa, conservative measures were always unsuccessful.
Conclusions
TBORN occurs earlier in older patients. While diffuse disease is less common than localized disease, it occurs more frequently in patients with diabetes, history of 3D‐CRT, and periauricular skin malignancies. Conservative management is appropriate for localized disease, while surgery is often necessary for diffuse disease. The prognostic factors identified helped propose a TBORN staging system and treatment guidelines which may improve patient risk stratification and disease management.
Level of Evidence
4 Laryngoscope, 131:2578–2585, 2021</abstract><cop>Hoboken, USA</cop><pub>John Wiley & Sons, Inc</pub><pmid>34287898</pmid><doi>10.1002/lary.29758</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-5074-5460</orcidid><orcidid>https://orcid.org/0000-0001-9015-4895</orcidid><orcidid>https://orcid.org/0000-0003-3706-8781</orcidid><orcidid>https://orcid.org/0000-0001-6762-6807</orcidid><orcidid>https://orcid.org/0000-0001-8923-6527</orcidid><orcidid>https://orcid.org/0000-0003-1509-8971</orcidid><orcidid>https://orcid.org/0000-0003-2008-518X</orcidid><orcidid>https://orcid.org/0000-0001-9295-0174</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0023-852X |
ispartof | The Laryngoscope, 2021-11, Vol.131 (11), p.2578-2585 |
issn | 0023-852X 1531-4995 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9214913 |
source | Wiley Online Library Journals Frontfile Complete |
subjects | Diabetes Laryngoscopy osteoradionecrosis Patients radiation Radiation therapy Skin cancer Temporal bone |
title | Temporal Bone Osteoradionecrosis: An 18‐year, Single‐Institution Experience |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T13%3A10%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Temporal%20Bone%20Osteoradionecrosis:%20An%2018%E2%80%90year,%20Single%E2%80%90Institution%20Experience&rft.jtitle=The%20Laryngoscope&rft.au=Lovin,%20Benjamin%20D.&rft.date=2021-11&rft.volume=131&rft.issue=11&rft.spage=2578&rft.epage=2585&rft.pages=2578-2585&rft.issn=0023-852X&rft.eissn=1531-4995&rft_id=info:doi/10.1002/lary.29758&rft_dat=%3Cproquest_pubme%3E2553818414%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2580258711&rft_id=info:pmid/34287898&rfr_iscdi=true |